D. Y. Patil

Genome characterization of monkeypox cases detected in India: Identification of three sub clusters among A.2 lineage

The paper analyzes Monkeypox virus genomes from India, identifying three subclusters within the A.2 lineage and additional APOBEC3 mutations.

Low immune response after 1.5 years of primary SARS-CoV-2 infection and Covishield vaccination lead to SARS-CoV-2 reinfection

The paper examines six cases of SARS-CoV-2 reinfection following primary infection and Covishield vaccination, showing reduced hybrid immunity and the need for booster doses.

Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concerns

This study compares IgG and neutralizing antibody responses in vaccinated and unvaccinated individuals infected with the Omicron variant of SARS-CoV-2, showing reduced neutralization against Omicron compared to earlier variants.

Pathogenicity of SARS-CoV-2 Omicron in Syrian hamsters and its neutralization with different Variants of Concern

This study evaluates the pathogenicity of SARS-CoV-2 Omicron BA.1 in Syrian hamsters and finds reduced cross-neutralization against other variants.

An in vitro and in vivo approach for the isolation of Omicron variant from human clinical specimens

The paper isolates the Omicron variant from Syrian hamsters and compares its genetic changes to human clinical specimens and Vero CCL-81 cell passages.

Neutralization of Delta variant with sera of Covishield vaccinees and COVID-19 recovered vaccinated individuals

This study evaluates immune response in Covishield vaccinated and recovered individuals against the Delta variant, finding higher protection in breakthrough cases and recovered individuals compared to single or double vaccinated groups.

Neutralization against B.1.351 and B.1.617.2 with sera of COVID-19 recovered cases and vaccinees of BBV152

This study assesses the neutralization efficacy of sera from COVID-19 recovered cases and BBV152 vaccinees against SARS-CoV-2 variants B.1.351 and B.1.617.2, showing reduced titers but still protective responses.

Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1

This study compares neutralizing antibody responses in Covishield-vaccinated individuals and COVID-19 recovered subjects against B.1 and B.1.617.1 variants, finding higher neutralization in recovered subjects.

SARS CoV-2 variant B.1.617.1 is highly pathogenic in hamsters than B.1 variant

This study compares the pathogenicity of SARS-CoV-2 variants B.1 and B.1.617.1 in hamsters, finding B.1.617.1 causes greater body weight loss, higher viral load, and more severe lung lesions.

Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees

The paper assesses the neutralizing ability of sera from BBV152 vaccinees and convalescent COVID-19 patients against B.1.617 variants.

Comparison of the pathogenicity and virus shedding of SARS CoV-2 VOC 202012/01 and D614G variant in hamster model

This study compares the pathogenicity and virus shedding of SARS-CoV-2 VOC 202012/01 and D614G variants in hamsters, finding higher viral shedding and mild lung pathology with VOC 202012/01.